| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/22/2003 | CA2170757C Method of marking eukaryotic cells by the use of a cell surface receptor as a marker |
| 04/22/2003 | CA2137793C Crystallization of m-csf |
| 04/22/2003 | CA2113995C Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins |
| 04/22/2003 | CA2102623C Recombinant virus expressing carcinoembryonic antigen and methods of use thereof |
| 04/22/2003 | CA2101075C Peptides for the treatment of conditions caused by herpes virus infections |
| 04/22/2003 | CA2098295C G protein-coupled glutamate receptors |
| 04/22/2003 | CA2096975C Cell stress transcriptional factors |
| 04/22/2003 | CA2091678C Viral defective vaccine produced by transcomplementing cell line |
| 04/22/2003 | CA2076386C Identification and expression of insect steroid receptor dna sequence |
| 04/22/2003 | CA2054602C Method for assaying for a substance that affects an sh2-phosphorylated ligand regulatory system |
| 04/22/2003 | CA1341427C Variants of immunoglobulin gene superfamily member |
| 04/19/2003 | CA2408762A1 Antibodies for specifically detecting pathogenic prions of human origin, and detection methods carried out using these antibodies |
| 04/18/2003 | CA2404050A1 Mb-1 analogs and uses thereof |
| 04/17/2003 | WO2003031942A1 Reagents and methods useful for detecting diseases of the breast |
| 04/17/2003 | WO2003031940A2 Structural and cytoskeleton-associated proteins |
| 04/17/2003 | WO2003031939A2 Protein modification and maintenance molecules |
| 04/17/2003 | WO2003031650A2 Genes and proteins for prevention, prediction, prognosis and therapy of cardiovascular disease |
| 04/17/2003 | WO2003031642A2 lovE VARIANT REGULATOR MOLECULES |
| 04/17/2003 | WO2003031639A2 Isolated cryopyrins, nucleic acid molecules encoding these, and use thereof |
| 04/17/2003 | WO2003031631A1 Modification of plant responses to salt |
| 04/17/2003 | WO2003031623A1 Cocoa flavour precursor peptides |
| 04/17/2003 | WO2003031621A2 A human g protein coupled receptor |
| 04/17/2003 | WO2003031620A1 Novel class ii cytokine receptor |
| 04/17/2003 | WO2003031612A2 Method for determining cell cycle position |
| 04/17/2003 | WO2003031604A1 Gastrointestinal chemosensory receptors |
| 04/17/2003 | WO2003031603A1 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 04/17/2003 | WO2003031600A1 Saccharomyces-cerevisiae yeast strain with stable integration and expression of the nucleic acid sequence for a heterologous potassium ion channel |
| 04/17/2003 | WO2003031598A2 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 04/17/2003 | WO2003031595A2 Molecules for disease detection and treatment |
| 04/17/2003 | WO2003031590A2 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same |
| 04/17/2003 | WO2003031589A2 Peptides and related compounds having thrombopoietic activity |
| 04/17/2003 | WO2003031588A2 Hepatitis c virus vaccine |
| 04/17/2003 | WO2003031586A2 Acrp30-like polynucleotides, polypeptides, and antibodies |
| 04/17/2003 | WO2003031584A2 Axon repair |
| 04/17/2003 | WO2003031583A2 Generation of virus-like particles by vsv |
| 04/17/2003 | WO2003031582A2 Novel acidic mammalian proteins and polynucleotides encoding the same |
| 04/17/2003 | WO2003031581A2 Thioester-terminated water soluble polymers and method of modifying the n-terminus of a polypeptide therewith |
| 04/17/2003 | WO2003031578A2 Mammalian c-type lectins |
| 04/17/2003 | WO2003031577A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 04/17/2003 | WO2003031575A2 A hybrid fusion protein transcription regulator to induce interferon target gene expression |
| 04/17/2003 | WO2003031573A2 Toll-like receptor 3 signaling agonists and antagonists |
| 04/17/2003 | WO2003031572A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/17/2003 | WO2003031571A2 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 04/17/2003 | WO2003031568A2 Intracellular signaling molecules |
| 04/17/2003 | WO2003031566A2 Keratinocyte derived interferon |
| 04/17/2003 | WO2003031474A2 Cd137 as a proliferation factor for hematopoietic stem cells |
| 04/17/2003 | WO2003031473A1 Leukocyte inactivation module |
| 04/17/2003 | WO2003031472A2 Insulin mimetic amino acid sequences |
| 04/17/2003 | WO2003031471A1 Methods and compositions for production and purification of recombinant staphylococcal enterotoxin b (rseb) |
| 04/17/2003 | WO2003031470A2 Dna-expression construct for treatment of infections with leishmaniasis |
| 04/17/2003 | WO2003031469A2 Means for improving immune response |
| 04/17/2003 | WO2003031466A2 Angiotensin peptide-carrier conjugates and uses thereof |
| 04/17/2003 | WO2003031464A2 Remodeling and glycoconjugation of peptides |
| 04/17/2003 | WO2003031462A2 Nogo receptor-mediated blockade of axonal growth |
| 04/17/2003 | WO2003031461A2 N-formyl peptide receptor mediation of platelet chemotaxis toward injured cells and activation of immune response |
| 04/17/2003 | WO2003031322A1 Method for preparing cobalt-protein complex |
| 04/17/2003 | WO2003030936A1 Remedies for life style-related diseases or cibophobia and method of screening the same |
| 04/17/2003 | WO2003030932A1 Attenuated mutant newcastle disease virus strains for in ovo vaccination, method for preparing and their use |
| 04/17/2003 | WO2003030930A1 Human 3 relaxin |
| 04/17/2003 | WO2003030922A2 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis |
| 04/17/2003 | WO2003030885A2 Modulation of the adventitial tool-like receptor |
| 04/17/2003 | WO2003030866A1 Stable galenic freeze-dried pharmaceutical preparation of recombined carbohydrate-binding polypeptides |
| 04/17/2003 | WO2003030828A2 Nociceptin-based analgesics |
| 04/17/2003 | WO2003030825A2 CCAAT/ENHANCER BINDING PROTEIN-β (C/EBPβ IS A MOLECULAR TARGET FOR CANCER TREATMENT |
| 04/17/2003 | WO2003030824A2 Methods and compositions for treating dermal lesions |
| 04/17/2003 | WO2003030821A2 Albumin fusion proteins |
| 04/17/2003 | WO2003030652A1 Flax protein isolate and production |
| 04/17/2003 | WO2003030639A2 Methods for growing and imprinting fish using an odorant |
| 04/17/2003 | WO2003030624A2 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 04/17/2003 | WO2003030616A2 21132, a human g-protein coupled receptor family member and uses therefor |
| 04/17/2003 | WO2003030612A2 Methods for modulating activity of the fxr nuclear receptor |
| 04/17/2003 | WO2002094985A3 Beta-secretase substrates and uses thereof |
| 04/17/2003 | WO2002094863A3 INTERFERON-α INDUCED GENE |
| 04/17/2003 | WO2002085943A3 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof |
| 04/17/2003 | WO2002085930A3 Immunomodulating agents from parasitic worms and method for isolation thereof |
| 04/17/2003 | WO2002083727A3 Nucleic acid sequences of hyperplasies and tumors of the thyroid |
| 04/17/2003 | WO2002083072A3 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives |
| 04/17/2003 | WO2002081726A3 Modulation of gene expression in mouse genetic models of atherosclerosis |
| 04/17/2003 | WO2002077190A8 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 04/17/2003 | WO2002077188A3 Human serine/threonine kinase |
| 04/17/2003 | WO2002076486A3 Histidine-rich glycoprotein |
| 04/17/2003 | WO2002072622A3 Vaccine antigens against infection by chlamydia trachomatis |
| 04/17/2003 | WO2002070706A3 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 04/17/2003 | WO2002068468A3 Isolated human tumor supressor proteins, nucleic acid molecules encoding these human tumor supressor proteins, and uses thereof |
| 04/17/2003 | WO2002064615A3 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 04/17/2003 | WO2002061070A3 Environmentally regulated genes, involved in the virulence of streptococcus suis |
| 04/17/2003 | WO2002060163A9 Methods for increasing bone formation and enhancing bone accretion |
| 04/17/2003 | WO2002059248A9 A novel gene associated with regulation of adiposity and insulin response |
| 04/17/2003 | WO2002059151A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 04/17/2003 | WO2002057664A3 Bacillus thuringiensis insecticidal proteins |
| 04/17/2003 | WO2002055709A3 Rhodococcus cloning and expression vectors |
| 04/17/2003 | WO2002055667A3 Identification of an advanced sleep phase syndrome gene in humans |
| 04/17/2003 | WO2002052276A3 Protein s functional assay |
| 04/17/2003 | WO2002051990A3 Proteases of endogenous retroviruses, substrates thereof and method for screening inhibitors |
| 04/17/2003 | WO2002051237A9 Helicobacter proteins, nucleic acids and uses thereof |
| 04/17/2003 | WO2002050289A9 Methods for the production of multimeric proteins, and related compositions |
| 04/17/2003 | WO2002048708A3 Assay for anti-viral agent |
| 04/17/2003 | WO2002047713A3 Composition containing a mixture of growth factor for the treatment of renal injury |
| 04/17/2003 | WO2002039923A3 Inhibition of alpha-2 hs glycoprotein (ahsg/fetuin) in obesity and insulin control of glucose homeostasis |
| 04/17/2003 | WO2002033094A1 Antibody inhibiting vplf activity |